Contribution of calpain Lp82-induced proteolysis to experimental cataractogenesis in mice

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 6, 2000, Pages 1460-1466

  Nakamura, Yoshikuni ^a   Fukiage, Chiho ^a,b   Shih, Marjorie ^b   Ma, Hong ^b   David, Larry L ^b   Azuma, Mitsuyoshi ^a,b,c   Shearer, Thomas R ^b  

^a Kobe Steel   (Japan)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c SENJU PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALPAIN; CRYSTALLIN; LENS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL MODEL; ARTICLE; CATARACT; CATARACTOGENESIS; LENS; MASS SPECTROMETRY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

AMINO ACID SEQUENCE; ANIMALS; BUTHIONINE SULFOXIMINE; CALCIMYCIN; CALCIUM; CALPAIN; CATARACT; CYSTEINE ENDOPEPTIDASES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; IMMUNOBLOTTING; LENS, CRYSTALLINE; LIGHT; MASS SPECTROMETRY; MICE; MICE, INBRED ICR; MOLECULAR SEQUENCE DATA; ORGAN CULTURE TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; SCATTERING, RADIATION; SPECTROPHOTOMETRY, ATOMIC;

EID: 0034098098     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Croall DE, DeMartino GN. Calcium-activated neutral protease (Calpain) system: structure, function and regulation. Physiol Rev. 1991;71:813-847.
2. Sorimachi H, Ishiura S, Suzuki K. Structure and physiological function of calpains. Biochem J. 1997;328:721-732.
3. Sorimachi H, Tsukahara T, Okada-Ban M, Sugita H, Ishiura S, Suzuki K. Identification of a third ubiquitous calpain species-chicken muscle expresses four distinct calpains. Biochim Biophys Acta. 1995;1261:381-393.
4. Richard I, Broux O, Allamand V, et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 1995;81:27-40.
5. Ma H, Shih M, Hata I, Fukiage C, Azuma M, Shearer TR. Protein for Lp82 calpain is expressed and enzymatically active in young rat lens. Exp Eye Res. 1998;67:221-229.
6. Herasse M, Ono Y, Fougerousse F, et al. Expression and functional characteristics of calpain 3 isoforms generated through tissue-specific transcriptional and posttranscriptional events. Mol Cell Biol. 1999;19:4047-4055.
7. Fukiage C, Ma H, Azuma M, Shearer TR. Molecular cloning and sequence analysis of calpain Rt88 from rat retina/choroid [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1998;39(4):S43. Abstract nr 190.
8. Nakamura Y, Fukiage C, Ma H, Shih M, Azuma M, Shearer TR. Decreased sensitivity of lens-specific calpain Lp82 to calpastatin inhibitor. Exp Eye Res. 1999;69:155-162.
9. Shearer TR, Ma H, Shih M, Fukiage C, Azuma M. Calpains in the lens of the eye. In: Wang KKW, Yeun P-W, eds. CALPAIN: Pharmacology and Toxicology of Calcium-Dependent Protease. Philadelphia: Taylor & Francis: 1999:331-347.
10. Ma H, Hata I, Shih M, et al. Lp82 is the dominant form of calpain in young mouse lens. Exp Eye Res. 1999;68:447-456.
11. Fukiage C, Azuma M, Nakamura Y, Tamada Y, Shearer TR. Calpain-induced light scattering by crystallins from three rodent species. Exp Eye Res. 1997;65:757-770.
12. Raser KJ, Posner A, Wang KKW. Casein zymography: a method to study μ-calpain, m-calpain, and their inhibitory agents. Arch Biochem Biophys. 1995;319:211-216.
13. Azuma M, David LL, Shearer TR. Superior prevention of calcium ionophore cataract by E64d. Biochim Biophys Acta. 1992;1180: 215-220.
14. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
15. Towbin H, Steahelin T, Gordon J. Electrophoretic transfer of pro teins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 1979;76:4350-4354.
16. David LL, Varnum MD, Lampi KJ, Shearer TR. Calpain II in human lens. Invest Ophthalmol Vis Sci. 1989;30:269-275.
17. Calvin HI, Patel SA, Zhang JP, Li MY, Fu SCJ. Progressive modifications of mouse lens crystallins in cataracts induced by buthionine sulfoximine. Exp Eye Res. 1992;54:611-619.
18. Shearer TR, Shih M, Azuma M, David LL. Precipitation of crystallins from young rat lens by endogenous calpain. Exp Eye Res. 1995; 61:141-150.
19. Azuma M, Fukiage C, David LL, Shearer TR. Activation of calpain in lens: a review and proposed mechanism. Exp Eye Res. 1997;64: 529-538.
20. Shearer TR, Ma H, Shih M, Fukiage C, Nakamuru Y, Azuma M. Lp82 calpain during lens maturation and cataract formation. Curr Eye Res. 1998;17:1037-1043.
21. Sanderson J, Marcantonio JM, Duncan G. Calcium ionophore induced proteolysis and cataract: inhibition by cell permeable calpain antagonists. Biochem Biophys Res Commun. 1996;218:893-901.
22. Shearer TR, Shih M, Mizuno T, David LL. Crystallins from rat lens are especially susceptible to calpain-induced light scattering compared to other species. Curr Eye Res. 1996;15:860-868.
23. Ma H, Fukiage C, Azuma M, Shearer TR. Cloning and expression of mRNA for calpain Lp82 from rat lens: splice variant of p94. Invest Ophthalmol Vis Sci. 1998;39:454-461.
24. Kelley MJ, David LL, Iwasaki N, Wright J, Shearer TR. α-Crystallin chaperone activity is reduced by calpain II in vitro and in selenite cataract. J Biol Chem. 1993;25:18844-18849.
25. David LL, Shearer TR, Shin M. Sequence analysis of lens beta-crystallins suggests involvement of calpain in cataract formation. J Biol Chem. 1993;268:1937-1940.
26. Takemoto LJ. Identification of the in vivo truncation sites at the C-terminal region of alpha-A crystallin from aged bovine and human lens. Curr Eye Res. 1995;14:837-841.
27. Lund AL, Smith JB, Smith DL. Modifications of the water-insoluble human lens alpha-crystallins. Exp Eye Res. 1996;63:661-672.
28. Takemoto LJ. Release of alpha-A sequence 158-173 correlates with a decrease in the molecular chaperone properties of native alpha-crystallin. Exp Eye Res. 1994;59:239-242.